26-A-15266-ACC POOLED SAFETY ANALYSIS OF ZILEBESIRAN, AN INVESTIGATIONAL LONG-ACTING RNA INTERFERENCE THERAPEUTIC, FROM PHASE 2 STUDIES IN PATIENTS WITH HYPERTENSION

Journal of the American College of Cardiology 2026

View at publisher
Authors: Akshay Suvas Desai, MANISH SAXENA, Christopher B. Granger, Neha Jadeja Pagidipati, Renato D. Lópes, David Wheeler, Aletta Elisabeth Schutte, Lorna Bailey, Monica Bengus, Shruti Daga, Sean H. Rhyee, Daniel Stiglitz
+3 more Andrea Havasi, Dion Zappe, Michael A. Weber
DOI: 10.1016/j.jacc.2026.02.508
Cited by: 1

Fields of Study & Subjects

Pharmacogenetics and Drug Metabolism Alcoholism and Thiamine Deficiency Folate and B Vitamins Research

Publication details

Journal / source
Journal of the American College of Cardiology
Publisher
Elsevier BV
Volume
87
Issue
13
Pages
A205–A205
Publication date
27 March 2026
Language
EN